These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9125617)

  • 1. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.
    Hallak M; Senderowicz J; Cassel A; Shapira C; Aghai E; Auslender R; Abramovici H
    Am J Obstet Gynecol; 1997 Apr; 176(4):889-93. PubMed ID: 9125617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation.
    Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS
    J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis.
    Dizon-Townson DS; Nelson LM; Jang H; Varner MW; Ward K
    Am J Obstet Gynecol; 1997 Apr; 176(4):883-6. PubMed ID: 9125615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden: should we screen oral contraceptive users and pregnant women?
    Vandenbroucke JP; van der Meer FJ; Helmerhorst FM; Rosendaal FR
    BMJ; 1996 Nov; 313(7065):1127-30. PubMed ID: 8916702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study.
    Bergrem A; Dahm AE; Jacobsen AF; Sandvik L; Sandset PM
    Thromb Haemost; 2012 Dec; 108(6):1165-71. PubMed ID: 23015030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.
    Hirsch DR; Mikkola KM; Marks PW; Fox EA; Dorfman DM; Ewenstein BM; Goldhaber SZ
    Am Heart J; 1996 Jun; 131(6):1145-8. PubMed ID: 8644593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis.
    Sifontes MT; Nuss R; Hunger SP; Waters J; Jacobson LJ; Manco-Johnson M
    Am J Hematol; 1998 Jan; 57(1):29-32. PubMed ID: 9423813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to activated protein C--frequent etiologic factor for venous thrombosis.
    Simkova M; Simko F; Kovacs L
    Bratisl Lek Listy; 2001; 102(5):240-7. PubMed ID: 11725376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The frequency of venous thromboembolism in women with Leiden mutation in association with pregnancy and puerperium].
    Dulícek P; Malý J; Kalousek I; Beránek M; Pecka M
    Ceska Gynekol; 2005 Mar; 70(2):133-8. PubMed ID: 15918268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.
    Sartori MT; Simioni P; Patrassi GM; Theodoridis P; Tormene D; Girolami A
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):36-40. PubMed ID: 10726047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does the asymptomatic carriage of FV Leiden and FII prothrombin in heterozygous configuration represent the increased risk of thrombembolic complications during pregnancy, childbirth and postpartum?].
    Binder T; Vavrinková B; Hadacová I; Hrachovinová I; Salaj P; Hruda M
    Ceska Gynekol; 2012 Feb; 77(1):25-30. PubMed ID: 22536637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and pulmonary embolism in a young woman taking an oral contraceptive.
    DiSiena MR; Intres R; Carter DJ
    Am J Forensic Med Pathol; 1998 Dec; 19(4):362-7. PubMed ID: 9885932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden mutation in cerebral venous thrombosis.
    Zuber M; Toulon P; Marnet L; Mas JL
    Stroke; 1996 Oct; 27(10):1721-3. PubMed ID: 8841317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.